Literature DB >> 21979892

Expression of dual angiogenic/neurogenic growth factors in human primary brain tumors.

Maud Clemessy1, Robert C Janzer, Benoìt Lhermitte, Jean-Marie Gasc, Lucienne Juillerat-Jeanneret.   

Abstract

Brain tumors, benign or malignant, are characterized by a very high degree of vascularization. Recent accumulating evidence suggests that during development the neuronal wiring follows the same routes as the vasculature and that these two systems may share some of the same factors for guidance. Thus, expression of dual angiogenic/neurogenic growth factors was evaluated by in situ hybridization in human primary brain tumors of three different types, i.e., astrocytomas, oligodendrogliomas, and ependymomas, of increasing grades, in relation with the grade and type of the tumor. For this evaluation we selected vascular endothelial growth factor (VEGF-A) and its receptors VEGF-R1 and VEGF-R2 and the neuropilins 1 and 2 (NRP-1 and NRP-2), which have proangiogenic properties, platelet-derived growth factor (PDGF) receptor-beta (PDGF-Rβ), which is required for the functional maturation of blood vessels, the ephrins and their Eph receptors, angiotensinogen (AGT) and thrombospondin-2 (TSP-2), which have potential antiangiogenic properties, and netrin-1 (Net-1), which regulates vascular architecture. We show that the expression of the VEGF-NRP system, PDGF-Rβ, TSP-2, AGT, and Net-1 are differentially regulated, either increased or decreased, in relation with the type and grade of the tumor, whereas regulation of the ephrinB system does not seem to be relevant in these human brain tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979892     DOI: 10.1007/s11060-011-0715-1

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  28 in total

Review 1.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Authors:  Elena B Pasquale
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

Review 2.  Guidance of vascular development: lessons from the nervous system.

Authors:  Bruno Larrivée; Catarina Freitas; Steven Suchting; Isabelle Brunet; Anne Eichmann
Journal:  Circ Res       Date:  2009-02-27       Impact factor: 17.367

Review 3.  Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy.

Authors:  Tanya A Rege; Constance Y Fears; Candece L Gladson
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

4.  Thrombospondin-2 (TSP2) expression is inversely correlated with vascularity in glioma.

Authors:  M Kazuno; T Tokunaga; Y Oshika; Y Tanaka; R Tsugane; H Kijima; H Yamazaki; Y Ueyama; M Nakamura
Journal:  Eur J Cancer       Date:  1999-03       Impact factor: 9.162

5.  Retinoic acid alters the mechanism of attachment of malignant astrocytoma and neuroblastoma cells to thrombospondin-1.

Authors:  V Pijuan-Thompson; J R Grammer; J Stewart; R L Silverstein; S F Pearce; G P Tuszynski; J E Murphy-Ullrich; C L Gladson
Journal:  Exp Cell Res       Date:  1999-05-25       Impact factor: 3.905

Review 6.  Vascular endothelial growth factor.

Authors:  K H Plate; P C Warnke
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

7.  The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis.

Authors:  Georg Martiny-Baron; Philipp Holzer; Eric Billy; Christian Schnell; Joseph Brueggen; Mireille Ferretti; Niko Schmiedeberg; Jeanette M Wood; Pascal Furet; Patricia Imbach
Journal:  Angiogenesis       Date:  2010-08-29       Impact factor: 9.596

Review 8.  Netrin-1 and its dependence receptors as original targets for cancer therapy.

Authors:  Patrick Mehlen; Céline Guenebeaud
Journal:  Curr Opin Oncol       Date:  2010-01       Impact factor: 3.645

Review 9.  Different networks, common growth factors: shared growth factors and receptors of the vascular and the nervous system.

Authors:  Sabine Raab; Karl H Plate
Journal:  Acta Neuropathol       Date:  2007-05-10       Impact factor: 17.088

Review 10.  Netrin-1 and its receptors in tumour growth promotion.

Authors:  Agnès Bernet; Julien Fitamant
Journal:  Expert Opin Ther Targets       Date:  2008-08       Impact factor: 6.902

View more
  4 in total

1.  PKCα is involved in the progression of kidney carcinoma through regulating netrin-1/UNC5B signaling pathway.

Authors:  Bo Zhan; Chuize Kong; Kunfeng Guo; Zhe Zhang
Journal:  Tumour Biol       Date:  2013-03-23

2.  Role of helicase-like transcription factor (hltf) in the G2/m transition and apoptosis in brain.

Authors:  Rebecca A Helmer; Oded Foreman; Janet S Dertien; Marlyn Panchoo; Suhani M Bhakta; Beverly S Chilton
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

Review 3.  Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors.

Authors:  Manon Douyère; Pascal Chastagner; Cédric Boura
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

4.  The plasma peptides of Alzheimer's disease.

Authors:  Angelique Florentinus-Mefailoski; Peter Bowden; Philip Scheltens; Joep Killestein; Charlotte Teunissen; John G Marshall
Journal:  Clin Proteomics       Date:  2021-06-28       Impact factor: 3.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.